Strengthening Artz Sales Expansion into Outlying Chinese Regions
First written in FY2019-Q2. 6 of 20 entries say "Advanced", first in FY2019-Q3. Latest entry: FY2026-H1.
0 other companies' latest entry also says "Other".
- FY2026-H1China Artz increased due to shipment timingAnnual report
「Our sales declined 7.1% year on year, despite increases in Gel-One, a joint-function improver sold in the U.S., and China Alts, because of declines in Spartz FX, a joint-function improver sold in the U.S., and other products. The changes were mainly attributable to shipment timing.」
Our sales of Alts in China increased, but shipment timing was cited as the main factor behind the increase or decrease. The difficulty of forecasting market trends in China due to the expansion of the centralized procurement system also continued. - FY2025SoftenedAnnual report
「Local unit sales of Alts in China declined. Our net sales also declined from the previous fiscal year because shipment volumes decreased in the fourth quarter due to changes in materials.」
Both local unit sales and our net sales of Alts in China declined, also affected by the decrease in fourth-quarter shipment volumes resulting from changes in materials. - FY2024-Q3RestatedAnnual report
「Local unit sales of Alts in China increased on a rebound from the decline in outpatient visits caused by lockdowns in major cities during the same period of the previous year amid the resurgence of COVID-19. Our net sales increased substantially because there had been no shipments in the same period of the previous year due to changes in packaging materials, and because local unit sales grew.」
Local unit sales and our net sales of Alts in China increased substantially on a rebound from the previous year's lockdowns and the suspension of shipments resulting from changes in packaging materials. - FY2024-Q1Recovery from the rebound from the previous year's lockdowns and shipment suspensionAnnual report
「Local unit sales of Alts in China increased on a rebound from the decline in outpatient visits caused by lockdowns in major cities during the same period of the previous year amid the resurgence of COVID-19. Our net sales increased substantially because there had been no shipments in the same period of the previous year due to changes in packaging materials.」
Local unit sales and our net sales of Alts in China increased substantially on a rebound from lower sales due to lockdowns and the suspension of shipments resulting from changes in packaging materials in the same period of the previous year. - FY2023-Q3Sales declined even after shipments resumedAnnual report
「Local unit sales of Alts in China declined substantially due to restrictions on outpatient visits and other factors resulting from the resurgence of COVID-19. Our net sales also declined substantially because there were no shipments in the first quarter due to changes in packaging materials. Shipments resumed in August 2022.」
Local unit sales of Alts in China declined substantially due to restrictions on outpatient visits. Shipments, which had been suspended in the first quarter, resumed in August 2022, but our net sales declined substantially. - FY2023-Q2SoftenedAnnual report
「Lockdowns in major cities continued following the resurgence of COVID-19, and local sales of Alts in China declined substantially. The company's sales also declined substantially because there were no first-quarter shipments in connection with changes to packaging materials. Shipments resumed in August 2022 under the annual shipment plan.」
Local unit sales of Alts in China declined substantially as lockdowns continued in major cities. Shipments, which had been suspended in the first quarter, resumed in August 2022, but our cumulative net sales for the first half declined substantially. - FY2023-Q1SoftenedAnnual report
「Local sales of Alts in China declined substantially because the rate of medical consultations fell as a result of renewed lockdowns in major cities following the resurgence of COVID-19. The company made no shipments in the first quarter under its annual shipment plan because the sales partner had built up inventory in the previous fiscal year in connection with changes to packaging materials. Shipments are scheduled to resume in August 2022.」
Local unit sales of Alts in China declined substantially as lockdowns reduced the rate of outpatient visits, and there were no shipments during the quarter because the sales partner increased its inventory. Shipments were scheduled to resume in August 2022. - FY2022AdvancedAnnual report
「Local unit sales of Alts in China increased as a result of active promotional activities in regions that won centralized procurement contracts and increased orders from medical institutions concerned about distribution disruptions caused by the spread of COVID-19. Our net sales increased substantially, partly because shipments were brought forward due to changes in packaging materials.」
Local unit sales of Alts in China increased due to promotional activities in centralized procurement regions and increased orders from medical institutions. Our net sales also increased substantially with the addition of shipments brought forward. - FY2022-Q3Sales and revenue increased under price-control measuresAnnual report
「Although market conditions for Alts in China became increasingly challenging due to government price-control measures and other factors, local unit sales increased as a result of active promotional activities and the expansion of the sales organization. Our net sales increased substantially, partly because shipments were concentrated through the third quarter.」
Although market conditions for Alts in China became more challenging due to price-control measures and other factors, local unit sales increased through promotional activities and the expanded sales organization. Our net sales also increased substantially as shipments were concentrated through the third quarter. - FY2022-Q2AdvancedAnnual report
「Local unit sales of Alts in China increased as prescription-promotion activities were intensified. Our net sales increased substantially, partly because shipments were concentrated through the second quarter.」
For Alts in China, prescription-promotion activities were intensified, resulting in increases in local unit sales and our net sales. - FY2022-Q1AdvancedAnnual report
「Local unit sales and our net sales of Alts in China increased as promotional activities were strengthened.」
Local unit sales and our net sales of Alts in China increased as promotional activities were strengthened. - FY2021AdvancedAnnual report
「Alts in China was significantly affected by the spread of COVID-19 from January through March 2020, resulting in low local sales in the previous fiscal year. Sales recovered steadily from April 2020 onward, and both local unit sales and our net sales increased.」
Alts in China recovered from the low level recorded in the previous fiscal year due to the impact of the infectious disease, and both local unit sales and our net sales increased. - FY2021-Q3AdvancedAnnual report
「Although outpatient care continued to be restricted in some regions, the impact on the market remained limited, and local unit sales increased. Our net sales declined due to the impact of shipment adjustments to the sales partner in the second quarter.」
Local unit sales of Alts in China turned upward from the same level as in the same period of the previous year in the preceding quarter. Meanwhile, our net sales declined due to shipment adjustments to the sales partner in the second quarter. - FY2021-Q2SoftenedAnnual report
「Although outpatient care remained restricted in some regions, the Chinese Alts market was recovering, and local unit sales were at the same level as in the same period of the previous year. Our net sales declined due to shipment adjustments to the sales partner and other factors.」
The Chinese Alts market was recovering and local unit sales had returned to the level of the same period of the previous year, but our net sales declined due to shipment adjustments to the sales partner. - FY2020SoftenedAnnual report
「Local unit sales and our net sales of Alts in China declined due to the impact of reduced outpatient visits at medical institutions resulting from the spread of COVID-19.」
Although the sales expansion strategy for Alts in China continued, local unit sales and our net sales declined because of reduced outpatient visits resulting from COVID-19. - FY2020-Q3Decline in sales and revenue due to channel inventory adjustmentsAnnual report
「Although the sales expansion strategy for Alts in China continued to prove effective, local sales and our net sales declined due to channel inventory adjustments by the sales partner.」
Although the sales expansion strategy for Alts in China continued to prove effective, local sales and our net sales declined due to channel inventory adjustments by the sales partner. - FY2020-Q2RestatedAnnual report
「The sales expansion strategy for Alts in China continued to prove effective, and local unit sales increased, but our net sales declined due to foreign exchange effects.」
For Alts in China, local unit sales continued to increase under the sales expansion strategy, but our net sales declined due to foreign exchange effects. - FY2020-Q1RestatedAnnual report
「For Alts in China, strengthening the sales partner's sales force and its strategy of expanding sales in urban areas and surrounding regions proved effective, resulting in increases in local unit sales and our net sales.」
For Alts in China, the company continued to expand its sales force and pursue its strategy of expanding sales in urban areas and surrounding regions, resulting in increases in local unit sales and our net sales. - FY2019-Q3AdvancedAnnual report
「Strengthening sales expansion into urban areas and surrounding regions by the sales partner proved effective, resulting in increases in local sales and our sales of Alts in China.」
For Alts in China, the company reported increases in local sales and our sales after stronger sales expansion into urban areas and surrounding regions proved effective. - FY2019-Q2First statedAnnual report
「Local sales of Alts in China have been trending upward as sales expansion into surrounding areas, in addition to urban areas, has been strengthened. Our sales increased partly because of the rebound from inventory adjustments in the local market during the same period of the previous year.」
The company first disclosed measures to strengthen the expansion of Alts sales into surrounding areas in addition to urban areas in China.